Vertero Therapeutics
Clinical trials sponsored by Vertero Therapeutics, explained in plain language.
-
First human trial begins for experimental Parkinson's pill
Disease control Recruiting nowThis is the first human study testing a new oral medication called VT-5006 for Parkinson's disease. Researchers want to see if the drug is safe and how it moves through the body in both healthy volunteers and people with Parkinson's. The study involves taking single or multiple d…
Phase: PHASE1 • Sponsor: Vertero Therapeutics • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Scientists search for gut clues to Parkinson's disease
Knowledge-focused Recruiting nowThis study aims to understand how common and variable a specific gut bacteria gene called csgA is in people with Parkinson's Disease who also have digestive issues. Researchers will collect stool samples from 200 participants over time to measure this gene. The goal is to gather …
Sponsor: Vertero Therapeutics • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC